GLP-1 Cost Calculator

How Much Do Weight Loss Drugs Really Cost in 2026?

GLP-1 weight loss medications like Ozempic, Wegovy, Mounjaro, and Zepbound have become the most effective pharmaceutical weight loss tools ever developed — clinical trials show 15–26% body weight reduction over 12–18 months. In December 2025, the World Health Organization (WHO) issued its first global guideline on GLP-1 medicines for treating obesity, formally recommending these medications as part of a comprehensive treatment approach for adults with obesity — a landmark endorsement that affirms what clinical evidence has demonstrated for years. But the cost remains the biggest barrier to access. List prices range from $1,000 to $1,350 per month without insurance, putting these weight loss drugs out of reach for millions of people who could benefit from them.

The reality is more nuanced than the sticker shock suggests. Actual out-of-pocket costs for weight loss medications in 2026 are significantly lower than list prices, thanks to manufacturer self-pay programs, expanding insurance coverage for weight loss, Medicare pilot programs, and compounded alternatives. Our calculator compares every pricing option so you can find the most affordable path to the weight loss medication that's right for you.

Key update (2026): Novo Nordisk cut Ozempic and Wegovy weight loss injection prices to $349/month for self-pay patients. Eli Lilly offers Zepbound weight loss vials at $349/month through LillyDirect. Medicare began covering weight loss medications in 2026 with $50/month copays for qualifying beneficiaries.

How Our Weight Loss Drug Cost Calculator Works

This calculator uses verified 2026 pricing data from manufacturer programs (NovoCare, LillyDirect), pharmacy discount platforms, and Medicare/Medicaid pricing announcements. We compare weight loss drug costs across four pricing channels: list price (what the manufacturer charges wholesalers), self-pay price (direct-to-consumer weight loss programs), insured price (with copay cards), and compounded price (from licensed telehealth weight loss providers).

The calculator adjusts for dose level — most weight loss patients start at a low dose and titrate up over 3–4 months. Maintenance doses for weight loss cost more than starter doses for most medications. Enter your medication preference, insurance status, and dose level to see your personalized cost comparison across all available channels.

2026 Weight Loss Drug Price Comparison

Prices are estimates based on publicly available data as of April 2026. Actual weight loss medication costs vary by pharmacy, location, dose, and eligibility. Always confirm with your provider.

How to Save on Weight Loss Medications

1. Use Manufacturer Self-Pay Weight Loss Programs

Both major weight loss drug manufacturers offer direct-to-consumer pricing dramatically below retail. Novo Nordisk's NovoCare Pharmacy sells Ozempic at $199/month for the first two fills and $349/month thereafter — available to anyone paying out of pocket for weight loss treatment. LillyDirect offers Zepbound weight loss vials at $349/month for self-pay patients.

These weight loss programs are designed for patients without insurance coverage or whose insurance excludes weight loss medications. Enrollment is straightforward through each manufacturer's website or pharmacy partner. No income verification is required — the self-pay price is available to anyone regardless of financial situation.

2. Check Insurance Coverage for Weight Loss

Insurance coverage for weight loss medications has expanded significantly in 2025–2026. The medical community's recognition that obesity is a chronic disease — not a lifestyle choice — has pushed more insurers to cover GLP-1 weight loss drugs. With commercial insurance and a manufacturer copay card, your monthly cost for weight loss medication can drop to as little as $25.

The process: your doctor submits a prior authorization for weight loss treatment. If approved, the insurer covers the bulk of the weight loss drug cost. You then apply the manufacturer's copay card to reduce your remaining copay to $25 or less.

Key eligibility criteria most insurers require for weight loss drug coverage: BMI of 30+ (obese), or BMI of 27+ (overweight) with at least one weight-related comorbidity such as hypertension, Type 2 diabetes, high cholesterol, or sleep apnea. Documentation of previous weight loss attempts (diet, exercise, behavioral modification) may also be required.

If your plan previously denied coverage for weight loss medications, it's worth resubmitting — many plans have updated their formularies in 2025–2026 as evidence of cardiovascular and metabolic benefits beyond weight loss has accumulated.

3. Consider Compounded Weight Loss Medications

Licensed compounding pharmacies produce semaglutide and tirzepatide for weight loss at $149–$349/month — a fraction of brand-name prices. Telehealth weight loss platforms like Hims, Hers, Peak Wellness, and others offer compounded GLP-1 weight loss programs that include medical evaluation, prescription, and medication delivery in one package.

Safety considerations for compounded weight loss drugs: Only use medications from licensed 503A or 503B compounding pharmacies. Verify that the prescribing provider is board-certified. Request a certificate of analysis confirming purity and potency. The FDA has issued warnings about unregulated operators selling counterfeit or improperly dosed weight loss products — particularly through social media ads and unlicensed online pharmacies.

Compounded weight loss medications are legally available during ongoing brand-name drug shortages. If shortages are resolved and brand-name weight loss drugs become fully available, the regulatory basis for compounding may change.

4. Medicare and Medicaid Weight Loss Drug Coverage (New in 2026)

The GENEROUS pilot program represents a landmark expansion: Medicare now covers GLP-1 weight loss medications for qualifying beneficiaries. Eligible patients — those with obesity (BMI 30+) or overweight (BMI 27+) with at least one weight-related condition — may pay as little as $50/month for weight loss drugs that previously cost $1,000+ out of pocket.

Medicare negotiated weight loss drug prices of $350/month for Wegovy and Zepbound (starting doses), trending down to $245 over two years. This coverage expansion reflects a policy shift toward treating obesity as a medical condition deserving pharmaceutical intervention, driven by evidence that weight loss medications reduce cardiovascular events, kidney disease, and long-term healthcare costs.

State Medicaid programs are opting into weight loss drug coverage separately. Check your state's current Medicaid formulary for GLP-1 weight loss medication availability.

5. Buy 90-Day Supplies and Use Tax-Advantaged Accounts

Ordering a 90-day supply of weight loss medication instead of monthly refills saves $15–$50/month through reduced dispensing fees and better program pricing. Many self-pay weight loss programs and insurance plans offer improved pricing for three-month fills.

Using HSA or FSA funds to pay for weight loss prescriptions effectively reduces cost by your marginal tax rate (20–35%), since these accounts use pre-tax dollars. A $349/month weight loss medication paid with HSA funds effectively costs $227–$279/month after tax savings — a meaningful reduction that many weight loss patients overlook.

Weight Loss Medication Guide: Which Drug Is Right for You?

Ozempic vs Wegovy for Weight Loss

Both contain semaglutide made by Novo Nordisk. The critical difference for weight loss patients: Ozempic is FDA-approved for Type 2 diabetes (doses up to 2mg), while Wegovy is specifically approved for chronic weight management (doses up to 2.4mg). Wegovy is also available as an oral weight loss pill, launched in January 2026 — the first oral GLP-1 approved specifically for weight loss.

Weight loss results: Clinical trials show semaglutide at the Wegovy dose (2.4mg) produces average weight loss of 15–17% of body weight over 68 weeks. At the lower Ozempic doses, weight loss averages 10–14%. The higher Wegovy dose provides more weight loss but also costs more.

Cost comparison for weight loss: Ozempic self-pay starts at $199/month (first two fills) then $349/month. Wegovy self-pay starts at $349/month. Many weight loss patients use Ozempic off-label because it's cheaper — though your doctor must prescribe it and insurance won't cover Ozempic for weight loss (only for diabetes). If you're paying out of pocket, the cost difference between Ozempic and Wegovy for weight loss is significant.

Mounjaro vs Zepbound for Weight Loss

Both contain tirzepatide made by Eli Lilly. Mounjaro is FDA-approved for Type 2 diabetes. Zepbound is approved for chronic weight management. Tirzepatide is a dual GIP/GLP-1 receptor agonist — activating two hormonal pathways instead of one — which clinical trials suggest produces greater weight loss than semaglutide alone.

Weight loss results: The SURMOUNT trials showed tirzepatide produces average weight loss of 20–26% of body weight over 72 weeks at the highest dose — significantly more than semaglutide's 15–17%. Some participants in clinical trials lost over 30% of body weight. For patients whose primary goal is maximum weight loss, tirzepatide (Zepbound) currently shows the strongest results.

Cost comparison for weight loss: Zepbound vials cost $349/month through LillyDirect for self-pay weight loss patients. Mounjaro at retail costs $995–$1,062/month. If you want tirzepatide for weight loss and you're paying out of pocket, Zepbound is dramatically cheaper than Mounjaro — same active ingredient, fraction of the price.

Oral Weight Loss Pills: The Next Frontier

The weight loss drug landscape is rapidly expanding beyond injections. Novo Nordisk launched the Wegovy oral pill in January 2026 — eliminating the needle barrier that deters many potential weight loss patients. Clinical trials show the oral form produces comparable (though slightly lower) weight loss to injectable Wegovy.

Eli Lilly's oral tirzepatide is progressing through FDA review for weight loss. Foundayo (orforglipron), a new oral weight loss drug from Eli Lilly, received FDA approval and is available starting at $149/month through GoodRx — potentially the most affordable branded weight loss medication to date.

Oral weight loss pills address the two biggest barriers simultaneously: cost (pills are cheaper to manufacture and distribute than injectable pens) and needle aversion (many people willing to take a daily pill refuse weekly injections). As oral options proliferate at lower price points, weight loss medication adoption is expected to accelerate dramatically.

What to Expect: Weight Loss Timeline and Side Effects

Weight Loss Timeline on GLP-1 Medications

Weeks 1–4 (titration start): Minimal weight loss (1–3 lbs) as you begin the lowest dose. Appetite reduction begins within the first week for most patients. The primary focus during this phase is tolerating the medication, not weight loss.

Months 1–3 (dose escalation): Weight loss accelerates as doses increase. Most patients lose 5–10% of body weight during this period. Appetite suppression becomes more pronounced. Food noise — the constant background thoughts about eating — diminishes significantly, which many weight loss patients describe as the most transformative effect.

Months 3–6 (approaching maintenance dose): Weight loss rate peaks. Most patients reach the full maintenance dose during this period. Average weight loss at 6 months: 10–15% of starting body weight.

Months 6–18 (continued weight loss and plateau): Weight loss continues but gradually slows. Most patients reach their maximum weight loss between 12–18 months. Average total weight loss: 15–26% of starting body weight depending on the medication and dose.

Beyond 18 months (maintenance): Weight stabilizes at the new lower level as long as medication continues. The medication doesn't stop working — it maintains the hormonal environment that supports the lower weight. Stopping medication typically leads to weight regain (see below).

Side Effects of Weight Loss Medications

Common (30–50% of patients, usually temporary): Nausea is the most reported side effect of GLP-1 weight loss drugs, typically worst during dose titration and resolving within 4–8 weeks at each dose level. Other common effects: diarrhea, constipation, vomiting, and abdominal discomfort. Eating smaller meals, avoiding high-fat and fried foods, and staying well-hydrated significantly reduce GI symptoms during the adjustment period.

Dose titration is key to tolerability. Starting at the lowest dose and stepping up every 4 weeks gives your body time to adjust. Patients who rush titration (skipping dose levels or increasing too quickly) experience dramatically worse nausea and GI side effects. Follow your provider's titration schedule — the path to your weight loss goal doesn't benefit from faster dose escalation.

Less common but important for weight loss patients: Gallbladder issues occur in approximately 1–3% of patients, likely related to the rapid weight loss itself (not the medication specifically — rapid weight loss from any cause increases gallstone risk). Pancreatitis is rare but serious — severe, persistent abdominal pain requires immediate medical attention. Muscle loss can accompany fat loss, especially without resistance training and adequate protein — weight loss patients should combine medication with strength training and 0.7–1.0g protein per pound of body weight to preserve lean mass.

What Happens When You Stop Weight Loss Medication?

Weight regain after discontinuing GLP-1 weight loss drugs is well-documented. Studies show approximately two-thirds of lost weight is regained within one year of stopping medication. This isn't a failure of willpower — it's biology. The hormonal signals that GLP-1 medications modify (appetite, satiety, gastric emptying) return to pre-treatment levels when the drug is removed.

This reality has shifted the medical consensus: most obesity medicine specialists now recommend GLP-1 weight loss medications as long-term chronic therapy rather than short-term courses. Just as blood pressure medication is taken continuously to maintain healthy blood pressure, weight loss medication is increasingly viewed as continuous treatment to maintain healthy weight.

The cost implications are significant — weight loss medication at $150–$500/month represents an ongoing annual expense of $1,800–$6,000. Our calculator helps you find the most affordable long-term option, because the cheapest monthly cost matters enormously when multiplied across years of maintenance therapy.